Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols. (Q52983052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Young Chul Youn

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

11

Seong Soo A An

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

7

Vo Van Giau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Min Jeong Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Jee-Young Han

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

So Young Park

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Jae-Won Jang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

In Kook Chun

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Eva Bagyinszky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Kun Taek Lim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Sung Min Kang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Young Ho Park

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

SangYun Kim

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

1 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

Journal of Alzheimer's Disease

4 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

1403-1413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

What cognitive changes can be expected with normal ageing?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Relationships between biomarkers in aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Amyloid-beta 42 adsorption following serial tube transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160143

21 January 2018

Identifiers

DOI

10.3233/JAD-160143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27163824%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference